Quality-of-life Outcomes and Patient-reported Outcome Measures After Penile-preserving Surgery to Treat Penile Cancer: A Systematic Review and Meta-analysis
In brief
Penile-preserving surgery links to better quality of life, but measures are unvalidated
A review of 34 observational studies found penile-preserving surgery was associated with better quality-of-life outcomes than more radical surgery, though urinary benefits were limited. The associations weakened when higher-risk studies were excluded, and more than 20 assessment tools were used, none validated for this surgery - leaving the size and certainty of the benefit unclear.
- Journal
- European urology focus (Q1)
- Published
- 10 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Kramer Chall, Siddharth Komperla, Ravish Seeruthun, Simran Hayre, Hussain M Alnajjar, Karl H Pang, et al.
- PMID
- 43009388
- DOI
- 10.1016/j.euf.2026.10.019
Why clinicians should know about it
- Picked for Urology (top studies of the week, 15 November 2026): Penile cancer surgery outcomes include function and quality of life
Abstract
CONTEXT: Penile-preserving surgery (PPS) is recommended for localised penile cancer (PeCa) being less radical than traditional penectomies and likely to improve post-operative morbidity; however, its impact on health-related quality-of-life (HRQoL) outcomes remains incompletely synthesised. OBJECTIVES: The aim of this review is to evaluate the reported HRQoL outcomes after PPS for PeCa and present the current methods used to assess these outcomes to determine the current utilisation of patient-reported outcome measures. EVIDENCE ACQUISITION: The review was registered with PROSPERO (CRD42022308047) and conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, MEDLINE, Embase, and Cochrane were searched up to March 1, 2026 (inclusive) for all studies reporting any HRQoL outcomes in adult men undergoing PPS (circumcision, wide local excision, glansectomy, and glans resurfacing) for primary PeCa. Revision surgeries and reviews were excluded. EVIDENCE SYNTHESIS: All included studies (N = 34) were observational, with no randomised controlled trials identified. Most studies were of reasonable quality; however, HRQoL was inconsistently reported as a secondary outcome. Risk differences and standardised mean differences were calculated in RevMan version 5.4 (The Cochrane Collaboration; London, UK), and dichotomous outcomes were analysed using Microsoft Excel version 17.0 (Microsoft Corporation, Washington, USA). Patient-reported outcome measures (PROMs) were explored through four domains: sexual and urinary function, cosmesis, and global HRQoL. Overall, PPS was seemingly associated with better outcomes compared with non-PPS techniques, although urinary function remains a challenge with limited benefits observed. Sensitivity analyses excluding high-risk-of-bias studies attenuated several pooled estimates, removing statistical significance. More than 20 different PROM assessment tools were identified; none were validated for use in PPS. CONCLUSIONS: PPS was associated with more favourable HRQoL outcomes, although the magnitude and certainty of these associations remain unclear. Future work should focus on developing a validated, PPS-specific PROM to standardise outcome reporting and guide patient care.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.